Intravascular lithotripsy
Shockwaves delivered through a balloon catheter to crack calcium in arteries.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 14, 19, 12, 21, 14.
All papers from the last 12 months
236 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Intravascular Lithotripsy for Calcified Femoral Artery Lesions in Patients with Peripheral Arterial Disease: An Early Single-Center Feasibility ExperienceAnn Vasc Surg2026 NovPMID 42448034
- Precision Imaging Evaluation and Clinical Application Progress of Vascular Calcification in Lower Extremity Peripheral Artery DiseaseAnn Vasc Surg2026 NovPMID 42392505Review
- Intravascular Lithotripsy-Assisted Femoropopliteal Revascularization for Heavily Calcified Chronic Limb-Threatening Ischemia: Midterm Outcomes from a Single-Center Retrospective StudyAnn Vasc Surg2026 NovPMID 42331217
- Optical Coherence Tomography-Guided Calcium Modification for a Complex Calcified Nodule With Circumferential Calcium: From Debulking to FracturingJACC Case Rep2026 Oct 16PMID 42886141
- Treatment of calcified coronary lesions with intravascular lithotripsy: experience of a regional French centreAnn Cardiol Angeiol (Paris)2026 Oct 10PMID 42859113
- Real-World Predictors and Temporal Trends in Intravascular Imaging Use During Percutaneous Coronary Intervention in a Publicly Funded Health SystemHeart Lung Circ2026 Oct 9PMID 42855338
- Lipid-Rich Plaque Beneath Dense Calcium: Imaging-Guided Lithotripsy in Calcified Double-Vessel DiseaseJACC Case Rep2026 Oct 7PMID 42847579
- Intravascular Lithotripsy in Left Main Stem Percutaneous Coronary InterventionCatheter Cardiovasc Interv2026 Oct 7PMID 42842313
- Contemporary Endovascular Treatment of Femoropopliteal Disease: Lesion Preparation, Antiproliferative Therapies, and Emerging TechnologiesJ Clin Med2026 Oct 2PMID 42882111Review
- Beyond the Learning Curve: Integrating Coronary Intravascular Lithotripsy into Contemporary Calcium ModificationArq Bras Cardiol2026PMID 42848623
More cardiology trends
All specialties →Factor XI inhibitors
A newer class of anticoagulants that target factor XI or XIa.
Key point: Adding an FXIa inhibitor to standard antiplatelet therapy after acute noncardioembolic ischemic stroke or TIA reduces stroke recurrence without evidence of increased bleeding risk.
Colchicine in cardiovascular disease
Colchicine as an anti-inflammatory therapy in coronary and cardiovascular disease.
Key point: Low-dose colchicine has demonstrated modest reductions in cardiovascular events, although results across trials have been inconsistent.
Renal denervation
A catheter procedure targeting renal nerves to lower blood pressure.
New antihypertensive drugs
New blood pressure drugs, including aldosterone synthase inhibitors and zilebesiran.
Key point: Aldosterone-targeted therapies, including aldosterone-synthase inhibitors and spironolactone, provide clinically meaningful systolic blood pressure reductions in resistant hypertension without increasing serious adverse events.
CETP inhibitors
Drugs that block cholesteryl ester transfer protein, studied for lowering LDL cholesterol.
Vutrisiran
Studies of vutrisiran, an RNA interference therapy for transthyretin amyloidosis.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"intravascular lithotripsy"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.